Approval · Notice of Compliance 4428 · 1996
GEMZAR: Notice of Compliance 4428
Issued December 23, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4428
- Date
- December 23, 1996
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic
Products in this notice
Medicinal ingredients
- GEMCITABINE HYDROCHLORIDE 200 MG per VIAL
- GEMCITABINE HYDROCHLORIDE 1 G per VIAL